GL1X · GenesisL1 explorer

Research workbench

Crystal structure of SARS-cov-2 main protease (NSP5) in complex with compound 18

Analyse Crystal structure of SARS-cov-2 main protease (NSP5) in complex with compound 18 in the GL1X research workbench: secondary structure, accessibility, pockets, interfaces, conservation, variants, modifications, peptides, crosslinks and neighbours on the 3D structure.

PDB
7QBB
Type
protein
Length
304 residues
Chains
1
Method
x-ray diffraction
Collection
MolNFT v1 / PDB
Contract
0xDE3723766Bc32dcACD03C17BaA400A7B36837Eba
Owner
0x3396CDB397284571d12822B4ae1189a8E22AAAAA
Molecule
3C-like proteinase NSP5
EC
3.4.22.69
UniProt
P0DTD1
Ligands
V1B
Pockets
2 · best druggability 0.56

Structure

x-ray diffraction · 1 distinct chain · 26% helix, 29% strand (DSSP).

ChainMoleculeTypeResiduesSecondary structureUniProt
A3C-like proteinase NSP5 (EC 3.4.22.69)protein30426% helix, 29% strandP0DTD1

Ligands and binding sites

  • V1B · 7-isoquinolin-4-yl-2-phenyl-5,7-diazaspiro[3.4]octane-6,8-dione · ligand · chains A
  • DMS · Dimethyl sulfoxide · additive · 2 copies · chains A

Binding sites are the residues within 4.5 Å of a ligand's heavy atoms.

Pockets

2 pockets found on a 1 Å grid, 2 with a druggability of 0.5 or more.

PocketVolume (ų)DruggabilityBuriednessLining residuesInside
12140.560.7928V1B
22270.530.7740DMS

Compared structures

  • 7QBB · Crystal Structure of SARS-CoV-2 main protease (Nsp5) in complex with compound 18 · the same entry in another collection · chain A against A, TM-score 1.00

Analyse

GL1X is a live explorer of the GenesisL1 blockchain. Turn on JavaScript for search, charts and interactive views.